Objective: Patients treated for nonfunctioning pituitary macroadenomas (NFMAs) have fatigue and alterations in sleep characteristics and sleep-wake rhythmicity frequently. As NFMAs often compress the optic chiasm, these complaints might be related to dysfunction of the adjacent suprachiasmatic nucleus (SCN). We aimed to explore whether indirect indices of SCN functioning are altered in the long term after surgery for NFMAs. Methods: We studied 17 NFMA patients in long-term remission after transsphenoidal surgery, receiving adequate and stable hormone replacement for hypopituitarism, and 17 control subjects matched for age, gender, and BMI. Indirect indices of SCN function were assessed from 24-h ambulatory recordings of skin and core body temperatures, blood pressure, and salivary melatonin levels. Altered melatonin secretion was defined as an absence of evening rise, considerable irregularity, or daytime values O3 pg/ml. We additionally studied eight patients treated for craniopharyngioma. Results: Distal-proximal skin temperature gradient did not differ between NFMAs and control subjects, but proximal skin temperature was decreased during daytime (PZ0.006). Core body temperature and non-dipping of blood pressure did not differ, whereas melatonin secretion was often altered in NFMAs (OR 5.3, 95% CI 0.9-30.6). One or more abnormal parameters (R2.0 SDS of control subjects) were observed during nighttime in 12 NFMA patients and during daytime in seven NFMA patients. Similar patterns were observed in craniopharyngioma patients. Conclusion: Heterogeneous patterns of altered diurnal rhythmicity in skin temperature and melatonin secretion parameters were observed in the majority of patients treated for NFMAs. On a group level, both NFMA and craniopharyngioma patients showed a lower daytime proximal skin temperature than control subjects, but other group averages were not significantly different. The observations suggest altered function of central (or peripheral) clock machinery, possibly by disturbed entrainment or damage of the hypothalamic SCN by the suprasellar macroadenoma or its treatment.
Introduction
Nonfunctioning pituitary macroadenomas (NFMAs) often cause pituitary insufficiency and visual impairments due to compression of the optic chiasm. In case of visual field defects, transsphenoidal surgery is the treatment of choice, resulting in the improvement of visual function in the majority of patients (1) . Selected patients require treatment by postoperative radiotherapy (2) .
We previously reported that patients treated for NFMAs by surgery suffer in the long term from impaired quality of life, increased daytime somnolence, fatigue, and sleeping difficulties (3) . In addition, polysomnography showed a lower sleep efficiency and less rapid eye movement (REM) sleep, while actigraphy showed fragmentation of the sleep-wake rhythm and longer sleep duration (3) .
It has been postulated that the complaints of fatigue and somnolence can, at least in part, be attributed to hypopituitarism, hormonal replacement therapy (4) , and/or an apathy syndrome (5) . An alternate hypothesis holds that these complaints result from dysfunction of the suprachiasmatic nucleus (SCN). The SCN consists of a small group of hypothalamic neurons located in direct proximity to the optic chiasm, controlling the sleep-wake cycle and coordinating this with circadian rhythms in other brain areas and other tissues (6) . Indirect support for this line of thought has been provided by a recent study in which a history of a suprasellar tumor with permanent visual field defects (NFMA in one of five patients) was associated with a reduced arginine vasopressin immunoreactivity in post-mortem SCN tissue (7) .
Our aim is to explore whether diurnal parameters reflecting SCN function are altered in the long term after surgery for NFMAs. We investigated a comprehensive set of indices of SCN function consisting of 24-h ambulatory recordings of blood pressure, skin and core body temperatures, and salivary melatonin levels. We compared the results with those of healthy control subjects matched for gender, age, and BMI. For illustrative purposes, we additionally examined a small number of patients treated for craniopharyngioma, as a model for usually more extensive damage, inter alia to the hypothalamus (8) .
Subjects and methods

Subjects
Patients were selected from a database containing all patients consecutively treated by transsphenoidal surgery for NFMAs in our institution (nZ226), between 1960 and 2008. Inclusion criteria were stable and adequate substitution of pituitary insufficiencies for at least 6 months (see Supplementary Information File, see section on supplementary data given at the end of this article for definitions) and an age of 18-65 years. Patients using hypnotics or psychotropic medication were excluded, as were patients suffering from conditions that may alter circadian rhythmicity, i.e. sleep disorders, depression, hypertension, dyslipidemia, and diabetes mellitus. A total of 43 patients fulfilled the inclusion criteria, of whom 17 participated. The clinical characteristics (including age, gender, tumor extension, visual field defects, or adjuvant radiotherapy) of the participants did not differ from those who did not participate. Visual field defects were assessed by Goldmann perimetry and evaluated by an ophthalmologist, who was unaware of the outcomes of the study.
In this study 17 gender-, age-, and BMI-matched control subjects were recruited via advertisement in local newspapers, using the same inclusion and exclusion criteria except for pituitary pathology.
Additionally, we studied eight patients previously treated for craniopharyngioma by transsphenoidal surgery. Identical inclusion and exclusion criteria were used as for NFMAs, except that the presence of hypertension and dyslipidemia was allowed because these conditions are frequently present in craniopharyngioma patients. As the craniopharyngioma group size was small, unmatched to the control subjects, and with considerable comorbidity, these patients were studied for illustrative purposes, and the results will only be discussed concisely (for details, see Supplementary File).
Methods
Study design " In this exploratory study, we assessed diurnal rhythmicity in 17 NFMA patients and 17 control subjects, using 24-h recordings of blood pressure, skin temperature, core body temperature, and 36-h profiles of salivary melatonin level. Measurements were obtained at home to facilitate normal sleep, simultaneous with previously reported polysomnographic and actigraphic measurements (see Supplementary Fig. 1 for study schedule) (3) .
In eight patients treated for craniopharyngioma, we studied skin and core body temperatures, subjective complaints by questionnaires, sleep characteristics by polysomnography, and sleep-wake rhythmicity by actigraphy (see Supplementary File for methods and results from polysomnography, actigraphy, and questionnaires).
The Medical Ethical Committee of the Leiden University Medical Center approved this study, and all subjects gave written informed consent.
Recordings of 24-h skin and core body temperatures " Core body temperature was monitored for w24 h at 1 min intervals by an ingestible Capsule Sensor (Jonah, Mini Mitter Co, Bend, OR, USA), with an accuracy of G0.05 8C between 32 and 42 8C, and sent to the wearable Vitalsense monitor (Respironics, Bend, OR, USA). To minimize the influence of food and drinks, subjects were instructed to maintain an intake diary and consume only the products of 36-38 8C during the first 8 h.
Skin temperature was measured at 1 min intervals for 24 h using a wireless Thermochron iButton DS1921H (Maxim/Dallas Semiconductor Corp., San Jose, CA, USA), with a mean accuracy of K0.09 8C and precision of 0.05 8C (9) fixed to the skin using a Fixomul tape (Beiersdorf, Hamburg, Germany). An automated artifact rejection procedure as used by Lichtenbelt et al. (9) was applied to exclude extreme drops and rises in temperature. Distal skin temperature was defined as the average of the thenar eminence of both palms and the medial metatarsal area of the plantar side of both feet. Measurements at both infraclavicular areas, 1 cm supraumbilical, and the left mid-thigh on the rectus femoris muscle, were used to calculate the proximal skin temperature (10): 0.383!midthighC0.293!infraclavicularC0.324!supraumbilical. The distal-proximal gradient represents thermoregulatory skin blood flow of the extremities (11) . Data were analyzed separately for the day and night periods (diary times of being in or out of bed).
Melatonin sampling " Melatonin was measured in saliva, which is a reliable index of serum melatonin level (12) . Saliva was collected using Salivettes (Sarstedt, Nümbrecht, Germany) on two subsequent evenings (at 3, 2, and 1 h before and at habitual bedtime, and upon waking up spontaneously at night) and on the day in between (at awakening, 1 and 2 h after awakening, noon, and 3 p.m.) (13) .
Patients were instructed to remain seated for 10 min before sampling to minimize the influence of postural changes (14) , avoid eating or drinking for 30 min before sampling and report mucosal wounds (15) . From 4 h before bedtime, until habitual bedtime, subjects were instructed to remain in dim light, e.g. by dimming light such that reading is just possible, closing the curtains, not sitting close to a lamp, not using a computer, and staying at least 3 m away from a television. During the entire collection period, subjects were not allowed to consume food dyes, chocolate, or banana (tryptophan increases melatonin production (16)), and alcohol, caffeine, or nonsteroidal anti-inflammatory drugs (which decrease melatonin levels (17, 18, 19) ).
Samples were kept in the dark at 4 8C until the end of assessment, and then stored at K20 8C until analysis. Samples were centrifuged at 1800 g for 15 min and aliquots of 400 ml were added to RIA kit tubes (RK-DSM; Bühlmann Laboratories AG, Schönenbuch, Switzerland). The detection limit was 0.3 pg/ml and the intra-assay and inter-assay precisions were 7.9 and 11.7% respectively.
Melatonin data were fitted to a skewed baseline cosine function (SBCF, see 'Statistical analysis' section) (13) . Altered melatonin secretion was defined as an absence of evening rise, daytime values O3 pg/ml, or severe irregularity in melatonin secretion, as indicated by non-fitting of the SBCF. Outliers were defined as values that severely deviated from the prior and following sample and that prevented adequate SBCF fitting.
Measurement of 24-h blood pressure " During 24 h, using a Mobil-O-Graph v.12 (Industrielle Entwicklung Medizin (I.E.M.) technik GmbH, Stolberg, Germany) oscillometric blood pressure measurements were performed every 10 min (day) or 30 min (night) with an accuracy of G3 mmHg. Data were analyzed using Hypertension Management V6.02.040 (I.E.M. GmbH). Non-dipping of mean arterial pressure (MAP) in the evening was defined as MAP night/day !10% (20) .
Patterns of alterations in diurnal parameters " To evaluate the distribution of alterations in all diurnal parameters within the patient cohort, and to identify patterns of altered parameters, Z-scores were calculated for individual patients, based on the control subjects' average and S.D. Altered diurnal parameters were defined as those deviating by more than 2.0 SDS and are separated for nighttime; i.e. low distal-proximal gradient, a delayed trough time or decreased trough depth in nighttime core body temperature, no melatonin rise, or non-dipping of blood pressure, and daytime, i.e. increased distal-proximal gradient, increased core body temperature, or increased melatonin values. Results were compared with the Z-scores from polysomnography and actigraphy, which were reported previously (3).
Statistical analysis
The skewed baseline cosine function (SBCF) (13) was used to fit the melatonin data too. This function parsimoniously quantifies the typical fixed low level during daytime and allows for skewness of the nocturnal peak, i.e. differences in the steepness of the rising and falling limb of the melatonin peak:
ðcos ðxKf C vcos ðxKfÞÞKc C jcos ðxKf C vcos ðxKfÞÞKcjÞ Y represents the predicted value of melatonin at time x (in radians, 0-2!p). The five parameters are directly proportional to the baseline level (b, average level during daytime), the relative peak height (H, peak level), the width (c, duration of peak), the phase (4, in radians), and the skewness (v) of the peak. The best fit was calculated using the Levenberg-Marquardt algorithm for nonlinear curve fitting included in using SPSS for Windows, version 20.0 (SPSS, Inc.). The onset time of the rise from baseline was calculated as (4K0.5c)/(2p), the peak time as the time of the highest SBCF value, the absolute peak as bCH, and the skewness of the evening upslope as H/(top timeKstarting time of rise). Patients were instructed to maintain their habitual bedtime, and melatonin samples were collected relative to that bedtime. To correct for the influence of differences in habitual bedtime on the individual timing of melatonin secretion, the data of all subjects were aligned at the individual bedtimes. Unpaired Student's t-tests, Pearson's c 2 -test or Fisher's exact test, and Pearson's or Spearman's correlation were used when appropriate. Differences were considered statistically significant at P!0.05.
Results
Clinical characteristics
All 17 NFMA patients (age 26-65 years, eight females) had been treated by transsphenoidal surgery for suprasellar extension and were in remission, considered as absence of or stable residual adenoma, for a median of 8 years (range 1-18 years) ( Table 1 ). The tumor size according to Hardy's classification was invasive (III/IV) in six patients, extending into the suprasellar cistern in one, into the recesses of the third ventricle in 17 patients, and in the parasellar region in five patients; 14 patients (82%) presented with visual field defects that had resolved almost completely postoperatively; and five patients received postoperative radiotherapy for remnants or postoperative tumor growth. At inclusion, 29% had adrenocorticotropic hormone (ACTH) deficiency, 65% growth hormone (GH) deficiency (GHD), 59% thyroid-stimulating hormone deficiency, and 35% luteinizing hormone/follicle-stimulating hormone deficiency (four males and two females, the other females were postmenopausal). All patients received adequate stable replacement therapy for pituitary deficiencies except for GHD, which was untreated in three out of 11 GHD patients due to contraindications or patient's preference. As per inclusion criterion of the NFMAs group, all patients were otherwise healthy. The 17 control subjects did not differ from the NFMA patients in gender, age, or BMI.
Diurnal variation in skin and core body temperatures
Distal-proximal gradient did not differ significantly between NFMA patients and control subjects, but the proximal skin temperature during daytime was decreased in NFMA patients (mean difference 0.49 8C, 95% CI 0.15-0.84 8C, PZ0.006; Table 2 ). There were no significant group differences in the core body temperature or in any of the nighttime parameters. Within patients, lower proximal skin temperature during daytime correlated with more general fatigue (MFI-20 questionnaire; rZK0.523, PZ0.031) and lower physical function (SF-36 questionnaire; rZ0.558, PZ0.020). In addition, a higher distalproximal gradient during daytime correlated with less physical fitness (MFI-20; rZ0.479, PZ0.052 and SF-36; rZK0.560, PZ0.020).
Melatonin curves in saliva
In three NFMA patients and eight control subjects, a distinct outlier was removed to fit the SBCF, and in seven NFMA patients (vs two control subjects), the two subsequent evening rises were so differently timed that only the first evening was used for fitting (Table 3) . Abnormal melatonin secretion was observed in seven NFMA patients vs two control subjects (OR 5.3, 95% CI 0.9-30.6, PZ0.12). Of these seven NFMA patients, the SBCF curve could not be fitted in five NFMA patients due to either an absence of evening rise (nZ4) or considerable irregularity (nZ1). In one of the four patients with an absent evening rise, nighttime melatonin production was observed in a 0400 h sample. In the other three, no night samples were collected. In control subjects, only two curves could not be adequately fitted, both due to irregularity of the evening rise. However, nighttime melatonin production was observed in both of them. Furthermore, in three NFMA patients (vs zero control subjects), increased mid-daytime melatonin values were observed (4.1, 4.3, and 67.7 pg/ml respectively), indicating incomplete suppression of melatonin production during daytime. Within patients, altered melatonin secretion correlated with more sleep disturbances (PSQI questionnaire; rZ0.644, P!0.01) and lower physical function (SF-36 questionnaire; rZK0.486, PZ0.048). SBCF parameters of fitted curves did not differ significantly between patients and control subjects, nor did habitual bedtimes (2326 hG35 min vs 2340 hG39 min, PZ0.279).
Diurnal variation in blood pressure
No group differences in the physiological evening drop or morning rise in blood pressure were observed between NFMA patients and control subjects (Table 4) . Daytime systolic blood pressure was mildly increased in NFMA patients (mean difference 8.2 mmHg, 95% CI 0.3-16.2 mmHg, PZ0.042).
Patterns of alterations in diurnal parameters
Diurnal parameters during the night " Out of 17 NFMA patients, 12 (71%) showed at least one of the five possible abnormal parameters during the night (Fig. 1), i.e. a low distal-proximal gradient (nZ1), a delayed trough time (nZ2), or decreased trough depth (nZ3) in nighttime core body temperature, no melatonin rise (nZ4), or non-dipping of blood pressure (nZ2).
The two most illustrative cases showed a nighttime distal-proximal gradient of K6.4 and K1.6 SDS. In these cases, polysomnography revealed an increased sleep period (C2.4 and C1.4 SDS), decreased percentages 
Craniopharyngioma patients
Skin and core body temperatures " In accordance with the observations in NFMA patients, proximal skin temperature was decreased in craniopharyngioma patients when compared with control subjects (Supplementary File). In addition, the nighttime proximal skin temperature was also decreased, and the distal-proximal skin temperature gradient during the night was higher than control subjects.
Polysomnography and actigraphy " As reported in NFMA patients (3), craniopharyngioma patients had increased percentages of awakening at night, lower sleep efficiency, and decreased percentages of REM sleep, when compared with control subjects. Furthermore, a slight trend toward increased fragmentation of day-night rhythmicity was observed by actigraphy.
Questionnaires " Compared with control subjects, craniopharyngioma patients reported profoundly decreased quality of life, increased fatigue and sleepiness, and decreased sleep quality in questionnaires.
Discussion
The aim of this study was to explore whether indirect indices of diurnal SCN functioning were altered in the long term after surgery for NFMAs. The main results were decreased proximal skin temperature during daytime, and altered patterns of melatonin secretion in 41% of patients. We did not observe significant group differences in core body temperature and blood pressure rhythmicity.
Although increasing attention has been focused on hypothalamic function in patients with pituitary disease (Table 5) , research on diurnal rhythmic parameters is complex. The SCN rostrally projects into the adjacent preoptic area of the anterior hypothalamus that serves a central and direct role in the thermoregulation (21) . The well-established 24-h pattern in both core and skin temperature, especially the relative warming of distal skin (expressed as the distal-proximal gradient), is closely related to sleep initiation (22) . In addition to these direct effects of the SCN on thermoregulation, distal-proximal gradient is indirectly influenced via the effects of melatonin, secretion of which from the pineal gland is regulated by the SCN (23) . In addition to the direct Figure 1 Individual Z-scores of nonfunctioning pituitary macroadenomas (NFMAs) and craniopharyngioma patients. BP MAP, mean arterial blood pressure; CBT, core body temperature; DPG, distal-proximal skin temperature gradient; PST, proximal skin temperature. Table 5 Studies assessing temperature regulation, melatonin production, or blood pressure rhythms in adult patients with diseases in the suprasellar region. soporific effect on the CNS (23), melatonin strongly promotes distal skin warming through selective opening of arteriovenous anastomoses in the skin (24) . Although disruptions of temperature rhythmicity have been described in humans following a hypothalamic lesion (25, 26) , diurnal regulation of skin temperature has never been studied in a cohort of patients with NFMAs. However, our results are in general accordance with findings in other suprasellar or hypothalamic diseases ( Table 5 ). The decrease in proximal skin temperature that we observed might explain the alterations in sleep quality and daytime wakefulness reported previously (3), as decreased proximal skin temperature is related to an increased sleep latency in both narcoleptics and healthy persons (27, 28) , and to sleep depth (29) .
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In addition, altered melatonin secretion might explain the alterations, as 41% of NFMA patients either had high daytime values, no evening rise, or severe irregularity of melatonin secretion. By contrast, only two control subjects had irregularity of the evening rise. Melatonin has never been studied in NFMA patients, but the results are in general accordance with those in other pituitary tumors (Table 5) .
Blood pressure follows a distinct diurnal pattern (30) . Multisynaptic pathways connect the SCN to the heart (31) and the variations in blood pressure are abolished after a SCN lesion in rodents (32) . In addition, both melatonin (33) and skin temperature (34) modulate blood pressure rhythmicity. On the other hand, some have proposed that the effects of sleep and activity patterns (35, 36) , and sleep deprivation (37, 38) , influence variability in blood pressure more than the direct effects of circadian pacemakers. This, in addition to the exclusion of patients with hypertension, might explain as to why we did not observe differences in the evening drop or morning rise. Although diurnal patterns of blood pressure have not been studied in NFMA patients before, non-dipping has been inconsistently observed in patients with Cushing's syndrome, acromegaly, and GHD (Table 5) .
Parameters of hypothalamic diurnal rhythmicity were heterogeneously affected among NFMA patients. From a pathophysiological point of view, it is conceivable that variable damage of SCN and adjacent nuclei may be present in NFMAs, regarding the highly variable clinical presentations and an unknown suprasellar growth velocity before presentation. The heterogeneous patterns of alterations might therefore be explained by the great variety of areas within the SCN and its efferent projections that can be damaged by a pituitary macroadenoma, as illustrated by studies attempting to specifically ablate SCN in rodents (39) . In our cohort of NFMA patients, various patterns of altered night parameters were observed in 71% and of daytime parameters in 41% of the patients. The results suggest irreversible damage to the SCN in patients in long-term remission after being treated successfully for NFMAs. This suggestion is strengthened by a similar trend of an altered diurnal rhythmicity that we observed in craniopharyngioma patients, who are known to often exhibit hypothalamic dysfunction (8, 40) . In addition, the hypothesis is supported by our previous observation of altered sleep characteristics and sleep-wake rhythmicity in long-term postoperative follow-up for NFMAs (3). Other reports include decreased sleep duration after compression of the optic chiasm of miscellaneous origin (41) and increased adult sleep duration after cranial radiation therapy in childhood (42) .
Alternatively, the decreased sleep efficiency and altered sleep stage distribution that we observed in our previous study (3) , or intrinsic imperfections of hormone replacement therapy might cause or contribute to altered entrainment of central and peripheral clocks (43) , which in turn could influence diurnal rhythms of melatonin and temperature. However, this does not explain as to why patients with a history of NFMAs show disturbed sleep in the first place, even in the absence of hypopituitarism. Therefore, although the disturbed rhythmicity might also cause altered entrainment of clock genes, we believe that these macroadenoma cause damage in the hypothalamic region above the chiasm, resulting in the altered function of (and most importantly) the SCN inter alia.
If our hypothesis is correct, NFMA patients with complaints of insomnia, daytime fatigue, or daytime somnolence might benefit from treatment with melatonin, especially when the evening rise is absent. Additionally, behavioral therapy might improve daytime sleepiness, e.g. through regularization of sleep patterns by maintaining a regular schedule for going to bed and waking up, and engaging in stimulating activities and light exposure immediately after waking up (44) .
Several limitations of this study need to be addressed. Data were collected at home, providing a patient-friendly assessment of natural sleep resulting in reliable polysomnographic results and an acceptable group size. However, the disadvantage of this method was that melatonin could only be measured at night if patients were awake and environmental temperatures could not be standardized. The latter might have affected the distal skin temperature. Although we assessed a group of patients without comorbidity other than pituitary disease, we cannot exclude that the (variable) degree of hypopituitarism and its replacement influenced the results. However, this is an innate drawback of all human studies on pituitary disease. For example, oral contraceptives raise the core body temperature in young healthy women (45) . In agreement, we found an increased core body temperature (C3.8 SDS at day and C2.9 SDS at night) in two premenopausal NFMA patients using estrogen/progesterone replacement. However, exclusion of these patients did not alter the results.
Finally, as a consequence of the strict exclusion of patients with comorbidity, our cohort represents the healthiest subgroup of patients. It is conceivable that in patients with more comorbidity, the macroadenoma was more damaging, possibly with a higher likelihood of hypothalamic damage. This selection bias, although providing us with the most reliable outcome measurements, might have limited our probability of observing hypothalamic dysfunction.
In conclusion, heterogeneous patterns of altered diurnal rhythmicity in skin temperature and melatonin secretion parameters were observed in the majority of patients treated for NFMAs. At a group level, both NFMA and craniopharyngioma patients showed lower daytime proximal skin temperature than control subjects, but other group averages were not significantly different. The observed alterations might be caused by disturbed entrainment of central and peripheral clock machinery or damage of the hypothalamic SCN either caused by the suprasellar macroadenoma, or transsphenoidal surgery. Diurnal and autonomic parameters need to be further studied in larger cohorts of NFMA patients, under controlled and/or provoked circumstances.
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